Experienced in Angiomyoma

Dr. Emese Zsiros

Oncology
Hospital Of The University Of PA
3701 Market St, 
Philadelphia, PA 
Experienced in Angiomyoma
Hospital Of The University Of PA
3701 Market St, 
Philadelphia, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Emese Zsiros is an Oncologist in Philadelphia, Pennsylvania. Dr. Zsiros is rated as an Experienced provider by MediFind in the treatment of Angiomyoma. Her top areas of expertise are Ovarian Cancer, Cervical Cancer, Endometrial Cancer, Desmoplastic Small Round Cell Tumor, and Oophorectomy.

Her clinical research consists of co-authoring 51 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Oncology
Licenses
Obstetrics & Gynecology in NY
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MVP Health
  • EPO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 3 Less Insurance Carriers -

Locations

Hospital of the University of PA
3701 Market St, Philadelphia, PA 19104

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 1/2, Open-Label, Dose-Escalation, Safety and Tolerability Study of NC762 in Subjects With Advanced or Metastatic Solid Tumors
A Phase 1/2, Open-Label, Dose-Escalation, Safety and Tolerability Study of NC762 in Subjects With Advanced or Metastatic Solid Tumors
Enrollment Status: Terminated
Publish Date: April 22, 2025
Intervention Type: Drug
Study Drug: NC762
Study Phase: Phase 1/Phase 2
A Phase 1, Multicenter, Open-Label Study of SQZ-AAC-HPV as Monotherapy and in Combination With Immune Checkpoint Inhibitors in HLA-A*02+ Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors
A Phase 1, Multicenter, Open-Label Study of SQZ-AAC-HPV as Monotherapy and in Combination With Immune Checkpoint Inhibitors in HLA-A*02+ Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors
Enrollment Status: Terminated
Publish Date: February 23, 2024
Intervention Type: Drug, Biological
Study Drugs: SQZ-AAC-HPV, Ipilimumab, Nivolumab
Study Phase: Phase 1
A Phase II Evaluation of Pembrolizumab in Combination With IV Bevacizumab and Oral Metronomic Cyclophosphamide in the Treatment of Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
A Phase II Evaluation of Pembrolizumab in Combination With IV Bevacizumab and Oral Metronomic Cyclophosphamide in the Treatment of Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Enrollment Status: Completed
Publish Date: October 06, 2021
Intervention Type: Drug, Other, Biological
Study Drugs: Bevacizumab, Cyclophosphamide, Pembrolizumab
Study Phase: Phase 2
Life on the Go 2: Evaluating the Effect of Physical Activity of Patients With Recurrent Ovarian Cancer Using State of the Art Activity Tracking Device
Life on the Go 2: Evaluating the Effect of Physical Activity of Patients With Recurrent Ovarian Cancer Using State of the Art Activity Tracking Device
Enrollment Status: Completed
Publish Date: September 02, 2021
Intervention Type: Other, Device
Study Phase: Phase 2
View 3 Less Clinical Trials

51 Total Publications

Reflections on Medical Trainee Unions and Health Care Systems.
Reflections on Medical Trainee Unions and Health Care Systems.
Journal: JAMA
Published: September 25, 2025
Similar Doctors
Mark G. Cadungog
Advanced in Angiomyoma
Dr. Mark G. Cadungog
Oncology
Advanced in Angiomyoma
Dr. Mark G. Cadungog
Oncology

Gynecology Oncology Helen Graham Cancer Center, Suite 2335

4701 Ogletown Stanton Road, Suite 2335, 
Newark, DE 
 (278.0 miles away)
302-623-4285
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Mark Cadungog is an Oncologist in Newark, Delaware. Dr. Cadungog is rated as a Distinguished provider by MediFind in the treatment of Angiomyoma. His top areas of expertise are Vulvar Cancer, Endometrial Cancer, Malignant Mixed Mullerian Tumor, Hernia Surgery, and Gastrostomy.

M B. Thomas
Advanced in Angiomyoma
Dr. M B. Thomas
Oncology
Advanced in Angiomyoma
Dr. M B. Thomas
Oncology

LVH Gynecologic Oncology-1240 Cedar Crest

1240 S Cedar Crest Blvd, Suite 401, 
Allentown, PA 
 (237.0 miles away)
610-402-3650
Languages Spoken:
English, Hebrew, Hindi
See accepted insurances
Offers Telehealth

Philosophy of care | My philosophy is to simply help people. | Why I entered medicine | I believe it is a privilege to care for cancer patients. Dr. Thomas is rated as a Distinguished provider by MediFind in the treatment of Angiomyoma. His top areas of expertise are Endometrial Cancer, Endometrial Stromal Sarcoma, Malignant Mixed Mullerian Tumor, Ureteroscopy, and Hernia Surgery.

Advanced in Angiomyoma
Dr. Janos L. Tanyi
Oncology
Advanced in Angiomyoma
Dr. Janos L. Tanyi
Oncology

Jordan Center For Gynecologic Cancers

3400 Civic Center Boulevard, West Pavilion, 3rd Floor, 
Philadelphia, PA 
 (280.0 miles away)
800-789-7366
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Janos Tanyi is an Oncologist in Philadelphia, Pennsylvania. Dr. Tanyi is rated as a Distinguished provider by MediFind in the treatment of Angiomyoma. His top areas of expertise are Ovarian Cancer, Endometrial Cancer, Ovarian Carcinosarcoma, Ureteroscopy, and Bladder Reconstruction. Dr. Tanyi is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Zsiros's expertise for a condition
ConditionClose
View All 7 Distinguished Conditions
View All 16 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile